Author

Y. Drew

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Mukhopadhyay· 1 shared E. J. Willmore· 1 shared H. L. Smith· 1 shared N. J. Curtin· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Mukhopadhyay

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Differences in durability of PARP inhibition by clinically approved PARP inhibitors: implications for combinations and scheduling

H. L. Smith, E. J. Willmore, A. Mukhopadhyay, Y. Drew, N. J. Curtin

This paper compares the durability of PARP inhibition by five PARP inhibitors in ovarian cancer cells and shows rucaparib provides the longest-lasting inhibition, with implications for combination therapies with ATR inhibitors.

bioRxiv · Jan 24, 2022Pharmacology & Toxicology